nodes	percent_of_prediction	percent_of_DWPC	metapath
Gonadorelin—Pentagastrin—BCHE—peripheral nervous system neoplasm	0.0271	1	CrCbGaD
Gonadorelin—Pelvic pain—Topotecan—peripheral nervous system neoplasm	0.0214	0.0228	CcSEcCtD
Gonadorelin—Embolism—Tretinoin—peripheral nervous system neoplasm	0.0201	0.0215	CcSEcCtD
Gonadorelin—Embolism—Isotretinoin—peripheral nervous system neoplasm	0.0201	0.0215	CcSEcCtD
Gonadorelin—Redness—Tretinoin—peripheral nervous system neoplasm	0.0191	0.0204	CcSEcCtD
Gonadorelin—Redness—Isotretinoin—peripheral nervous system neoplasm	0.0191	0.0204	CcSEcCtD
Gonadorelin—Embolism—Alitretinoin—peripheral nervous system neoplasm	0.0152	0.0163	CcSEcCtD
Gonadorelin—Contusion—Tretinoin—peripheral nervous system neoplasm	0.0148	0.0158	CcSEcCtD
Gonadorelin—Contusion—Isotretinoin—peripheral nervous system neoplasm	0.0148	0.0158	CcSEcCtD
Gonadorelin—Redness—Alitretinoin—peripheral nervous system neoplasm	0.0145	0.0155	CcSEcCtD
Gonadorelin—Dysmenorrhoea—Topotecan—peripheral nervous system neoplasm	0.0143	0.0153	CcSEcCtD
Gonadorelin—GNRHR—GPCRs, Other—ADGRV1—peripheral nervous system neoplasm	0.0141	0.395	CbGpPWpGaD
Gonadorelin—Thromboembolism—Epirubicin—peripheral nervous system neoplasm	0.0135	0.0144	CcSEcCtD
Gonadorelin—Injection site reaction—Isotretinoin—peripheral nervous system neoplasm	0.0128	0.0137	CcSEcCtD
Gonadorelin—Injection site reaction—Tretinoin—peripheral nervous system neoplasm	0.0128	0.0137	CcSEcCtD
Gonadorelin—Injection site reaction—Melphalan—peripheral nervous system neoplasm	0.0127	0.0135	CcSEcCtD
Gonadorelin—Thromboembolism—Doxorubicin—peripheral nervous system neoplasm	0.0125	0.0133	CcSEcCtD
Gonadorelin—Contusion—Alitretinoin—peripheral nervous system neoplasm	0.0112	0.012	CcSEcCtD
Gonadorelin—Swelling—Tretinoin—peripheral nervous system neoplasm	0.0106	0.0113	CcSEcCtD
Gonadorelin—Swelling—Isotretinoin—peripheral nervous system neoplasm	0.0106	0.0113	CcSEcCtD
Gonadorelin—Injection site reaction—Alitretinoin—peripheral nervous system neoplasm	0.00973	0.0104	CcSEcCtD
Gonadorelin—Embolism venous—Epirubicin—peripheral nervous system neoplasm	0.00849	0.00906	CcSEcCtD
Gonadorelin—Swelling—Alitretinoin—peripheral nervous system neoplasm	0.00805	0.00859	CcSEcCtD
Gonadorelin—Embolism venous—Doxorubicin—peripheral nervous system neoplasm	0.00785	0.00838	CcSEcCtD
Gonadorelin—Abdominal discomfort—Tretinoin—peripheral nervous system neoplasm	0.00777	0.00829	CcSEcCtD
Gonadorelin—Abdominal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00777	0.00829	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Isotretinoin—peripheral nervous system neoplasm	0.00753	0.00804	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Tretinoin—peripheral nervous system neoplasm	0.00753	0.00804	CcSEcCtD
Gonadorelin—Pelvic pain—Epirubicin—peripheral nervous system neoplasm	0.00704	0.00751	CcSEcCtD
Gonadorelin—Embolism—Epirubicin—peripheral nervous system neoplasm	0.00667	0.00712	CcSEcCtD
Gonadorelin—Pelvic pain—Doxorubicin—peripheral nervous system neoplasm	0.00651	0.00695	CcSEcCtD
Gonadorelin—Redness—Epirubicin—peripheral nervous system neoplasm	0.00635	0.00677	CcSEcCtD
Gonadorelin—Swelling—Etoposide—peripheral nervous system neoplasm	0.00629	0.00671	CcSEcCtD
Gonadorelin—Embolism—Doxorubicin—peripheral nervous system neoplasm	0.00617	0.00659	CcSEcCtD
Gonadorelin—Angiopathy—Topotecan—peripheral nervous system neoplasm	0.00593	0.00633	CcSEcCtD
Gonadorelin—Immune system disorder—Topotecan—peripheral nervous system neoplasm	0.00591	0.0063	CcSEcCtD
Gonadorelin—Abdominal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00589	0.00628	CcSEcCtD
Gonadorelin—Angiopathy—Tretinoin—peripheral nervous system neoplasm	0.00589	0.00628	CcSEcCtD
Gonadorelin—Angiopathy—Isotretinoin—peripheral nervous system neoplasm	0.00589	0.00628	CcSEcCtD
Gonadorelin—Redness—Doxorubicin—peripheral nervous system neoplasm	0.00587	0.00626	CcSEcCtD
Gonadorelin—Immune system disorder—Melphalan—peripheral nervous system neoplasm	0.00578	0.00617	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Alitretinoin—peripheral nervous system neoplasm	0.00571	0.00609	CcSEcCtD
Gonadorelin—Erythema—Tretinoin—peripheral nervous system neoplasm	0.00565	0.00603	CcSEcCtD
Gonadorelin—Erythema—Isotretinoin—peripheral nervous system neoplasm	0.00565	0.00603	CcSEcCtD
Gonadorelin—Flatulence—Tretinoin—peripheral nervous system neoplasm	0.00556	0.00594	CcSEcCtD
Gonadorelin—Flatulence—Isotretinoin—peripheral nervous system neoplasm	0.00556	0.00594	CcSEcCtD
Gonadorelin—Breast disorder—Cisplatin—peripheral nervous system neoplasm	0.00547	0.00584	CcSEcCtD
Gonadorelin—Abdominal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00502	0.00535	CcSEcCtD
Gonadorelin—Breast pain—Epirubicin—peripheral nervous system neoplasm	0.00491	0.00524	CcSEcCtD
Gonadorelin—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00465	0.00496	CcSEcCtD
Gonadorelin—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.00462	0.00492	CcSEcCtD
Gonadorelin—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.00461	0.00492	CcSEcCtD
Gonadorelin—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.00461	0.00492	CcSEcCtD
Gonadorelin—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.00456	0.00486	CcSEcCtD
Gonadorelin—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00455	0.00485	CcSEcCtD
Gonadorelin—Breast pain—Doxorubicin—peripheral nervous system neoplasm	0.00454	0.00485	CcSEcCtD
Gonadorelin—Shock—Tretinoin—peripheral nervous system neoplasm	0.00453	0.00484	CcSEcCtD
Gonadorelin—Shock—Isotretinoin—peripheral nervous system neoplasm	0.00453	0.00484	CcSEcCtD
Gonadorelin—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.00452	0.00482	CcSEcCtD
Gonadorelin—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.00452	0.00482	CcSEcCtD
Gonadorelin—Angiopathy—Alitretinoin—peripheral nervous system neoplasm	0.00446	0.00476	CcSEcCtD
Gonadorelin—Angiopathy—Vincristine—peripheral nervous system neoplasm	0.0043	0.00459	CcSEcCtD
Gonadorelin—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.00428	0.00457	CcSEcCtD
Gonadorelin—Injection site reaction—Epirubicin—peripheral nervous system neoplasm	0.00426	0.00454	CcSEcCtD
Gonadorelin—Flatulence—Alitretinoin—peripheral nervous system neoplasm	0.00422	0.0045	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.00401	0.00428	CcSEcCtD
Gonadorelin—Fatigue—Topotecan—peripheral nervous system neoplasm	0.00401	0.00427	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00398	0.00425	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00398	0.00425	CcSEcCtD
Gonadorelin—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.00397	0.00424	CcSEcCtD
Gonadorelin—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.00397	0.00424	CcSEcCtD
Gonadorelin—Pain—Topotecan—peripheral nervous system neoplasm	0.00397	0.00424	CcSEcCtD
Gonadorelin—Constipation—Topotecan—peripheral nervous system neoplasm	0.00397	0.00424	CcSEcCtD
Gonadorelin—Pain—Tretinoin—peripheral nervous system neoplasm	0.00394	0.00421	CcSEcCtD
Gonadorelin—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00394	0.00421	CcSEcCtD
Gonadorelin—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00394	0.00421	CcSEcCtD
Gonadorelin—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.00394	0.00421	CcSEcCtD
Gonadorelin—Injection site reaction—Doxorubicin—peripheral nervous system neoplasm	0.00394	0.0042	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00393	0.00419	CcSEcCtD
Gonadorelin—Fatigue—Melphalan—peripheral nervous system neoplasm	0.00392	0.00418	CcSEcCtD
Gonadorelin—Pain—Melphalan—peripheral nervous system neoplasm	0.00389	0.00415	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.0038	0.00405	CcSEcCtD
Gonadorelin—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	0.00378	0.00404	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.00377	0.00402	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.00377	0.00402	CcSEcCtD
Gonadorelin—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00367	0.00392	CcSEcCtD
Gonadorelin—Erythema—Cisplatin—peripheral nervous system neoplasm	0.00365	0.00389	CcSEcCtD
Gonadorelin—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00364	0.00389	CcSEcCtD
Gonadorelin—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00364	0.00389	CcSEcCtD
Gonadorelin—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.00359	0.00383	CcSEcCtD
Gonadorelin—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00349	0.00373	CcSEcCtD
Gonadorelin—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.00348	0.00371	CcSEcCtD
Gonadorelin—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.00347	0.0037	CcSEcCtD
Gonadorelin—Shock—Alitretinoin—peripheral nervous system neoplasm	0.00344	0.00367	CcSEcCtD
Gonadorelin—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.00343	0.00365	CcSEcCtD
Gonadorelin—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00342	0.00365	CcSEcCtD
Gonadorelin—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.0034	0.00362	CcSEcCtD
Gonadorelin—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.0034	0.00362	CcSEcCtD
Gonadorelin—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00337	0.00359	CcSEcCtD
Gonadorelin—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00335	0.00358	CcSEcCtD
Gonadorelin—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00333	0.00356	CcSEcCtD
Gonadorelin—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00331	0.00353	CcSEcCtD
Gonadorelin—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00331	0.00353	CcSEcCtD
Gonadorelin—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.0033	0.00352	CcSEcCtD
Gonadorelin—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00329	0.00351	CcSEcCtD
Gonadorelin—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00326	0.00348	CcSEcCtD
Gonadorelin—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00326	0.00348	CcSEcCtD
Gonadorelin—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00326	0.00348	CcSEcCtD
Gonadorelin—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00325	0.00347	CcSEcCtD
Gonadorelin—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00322	0.00344	CcSEcCtD
Gonadorelin—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00322	0.00343	CcSEcCtD
Gonadorelin—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00318	0.00339	CcSEcCtD
Gonadorelin—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00315	0.00336	CcSEcCtD
Gonadorelin—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00315	0.00336	CcSEcCtD
Gonadorelin—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00311	0.00332	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00308	0.00329	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00302	0.00322	CcSEcCtD
Gonadorelin—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00301	0.00321	CcSEcCtD
Gonadorelin—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00299	0.00319	CcSEcCtD
Gonadorelin—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00299	0.00319	CcSEcCtD
Gonadorelin—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00298	0.00318	CcSEcCtD
Gonadorelin—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00298	0.00318	CcSEcCtD
Gonadorelin—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00295	0.00315	CcSEcCtD
Gonadorelin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00293	0.00313	CcSEcCtD
Gonadorelin—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00293	0.00313	CcSEcCtD
Gonadorelin—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00292	0.00311	CcSEcCtD
Gonadorelin—Headache—Topotecan—peripheral nervous system neoplasm	0.00291	0.00311	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00291	0.0031	CcSEcCtD
Gonadorelin—Fatigue—Vincristine—peripheral nervous system neoplasm	0.0029	0.0031	CcSEcCtD
Gonadorelin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00289	0.00309	CcSEcCtD
Gonadorelin—Headache—Tretinoin—peripheral nervous system neoplasm	0.00289	0.00308	CcSEcCtD
Gonadorelin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00289	0.00308	CcSEcCtD
Gonadorelin—Pain—Vincristine—peripheral nervous system neoplasm	0.00288	0.00307	CcSEcCtD
Gonadorelin—Constipation—Vincristine—peripheral nervous system neoplasm	0.00288	0.00307	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00286	0.00305	CcSEcCtD
Gonadorelin—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.00281	0.003	CcSEcCtD
Gonadorelin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00278	0.00296	CcSEcCtD
Gonadorelin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00276	0.00295	CcSEcCtD
Gonadorelin—Nausea—Topotecan—peripheral nervous system neoplasm	0.00276	0.00294	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00275	0.00294	CcSEcCtD
Gonadorelin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00274	0.00292	CcSEcCtD
Gonadorelin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00274	0.00292	CcSEcCtD
Gonadorelin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00273	0.00291	CcSEcCtD
Gonadorelin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.0027	0.00288	CcSEcCtD
Gonadorelin—Nausea—Melphalan—peripheral nervous system neoplasm	0.0027	0.00288	CcSEcCtD
Gonadorelin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00266	0.00284	CcSEcCtD
Gonadorelin—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.0026	0.00277	CcSEcCtD
Gonadorelin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00258	0.00275	CcSEcCtD
Gonadorelin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00257	0.00275	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00257	0.00274	CcSEcCtD
Gonadorelin—Pain—Cisplatin—peripheral nervous system neoplasm	0.00254	0.00272	CcSEcCtD
Gonadorelin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00251	0.00267	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.0025	0.00266	CcSEcCtD
Gonadorelin—GNRHR—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	0.00249	0.0698	CbGpPWpGaD
Gonadorelin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00248	0.00265	CcSEcCtD
Gonadorelin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00247	0.00264	CcSEcCtD
Gonadorelin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00241	0.00258	CcSEcCtD
Gonadorelin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.0024	0.00256	CcSEcCtD
Gonadorelin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00239	0.00255	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00235	0.00251	CcSEcCtD
Gonadorelin—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00235	0.00251	CcSEcCtD
Gonadorelin—Constipation—Etoposide—peripheral nervous system neoplasm	0.00233	0.00249	CcSEcCtD
Gonadorelin—Pain—Etoposide—peripheral nervous system neoplasm	0.00233	0.00249	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.00231	0.00247	CcSEcCtD
Gonadorelin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.0023	0.00246	CcSEcCtD
Gonadorelin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00224	0.00239	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00223	0.00238	CcSEcCtD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	0.00223	0.0625	CbGpPWpGaD
Gonadorelin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00222	0.00237	CcSEcCtD
Gonadorelin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00219	0.00234	CcSEcCtD
Gonadorelin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00219	0.00233	CcSEcCtD
Gonadorelin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00216	0.0023	CcSEcCtD
Gonadorelin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00214	0.00228	CcSEcCtD
Gonadorelin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00214	0.00228	CcSEcCtD
Gonadorelin—Headache—Vincristine—peripheral nervous system neoplasm	0.00211	0.00225	CcSEcCtD
Gonadorelin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00207	0.00221	CcSEcCtD
Gonadorelin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00204	0.00217	CcSEcCtD
Gonadorelin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00201	0.00214	CcSEcCtD
Gonadorelin—Nausea—Vincristine—peripheral nervous system neoplasm	0.002	0.00213	CcSEcCtD
Gonadorelin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00196	0.00209	CcSEcCtD
Gonadorelin—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.00195	0.00208	CcSEcCtD
Gonadorelin—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.00194	0.00207	CcSEcCtD
Gonadorelin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00193	0.00206	CcSEcCtD
Gonadorelin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00189	0.00202	CcSEcCtD
Gonadorelin—Erythema—Epirubicin—peripheral nervous system neoplasm	0.00187	0.002	CcSEcCtD
Gonadorelin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00187	0.00199	CcSEcCtD
Gonadorelin—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.00185	0.00197	CcSEcCtD
Gonadorelin—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.00181	0.00193	CcSEcCtD
Gonadorelin—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.0018	0.00192	CcSEcCtD
Gonadorelin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00177	0.00189	CcSEcCtD
Gonadorelin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00173	0.00185	CcSEcCtD
Gonadorelin—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.00173	0.00185	CcSEcCtD
Gonadorelin—Headache—Etoposide—peripheral nervous system neoplasm	0.00171	0.00182	CcSEcCtD
Gonadorelin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.00171	0.00182	CcSEcCtD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00165	0.0463	CbGpPWpGaD
Gonadorelin—Nausea—Etoposide—peripheral nervous system neoplasm	0.00162	0.00173	CcSEcCtD
Gonadorelin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00153	0.00163	CcSEcCtD
Gonadorelin—Shock—Epirubicin—peripheral nervous system neoplasm	0.0015	0.0016	CcSEcCtD
Gonadorelin—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.0015	0.0016	CcSEcCtD
Gonadorelin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00141	0.00151	CcSEcCtD
Gonadorelin—Shock—Doxorubicin—peripheral nervous system neoplasm	0.00139	0.00148	CcSEcCtD
Gonadorelin—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00139	0.00148	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00132	0.00141	CcSEcCtD
Gonadorelin—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.00132	0.00141	CcSEcCtD
Gonadorelin—Pain—Epirubicin—peripheral nervous system neoplasm	0.00131	0.00139	CcSEcCtD
Gonadorelin—Constipation—Epirubicin—peripheral nervous system neoplasm	0.00131	0.00139	CcSEcCtD
Gonadorelin—GNRHR—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00126	0.0352	CbGpPWpGaD
Gonadorelin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.00125	0.00133	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00122	0.0013	CcSEcCtD
Gonadorelin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.00122	0.0013	CcSEcCtD
Gonadorelin—Pain—Doxorubicin—peripheral nervous system neoplasm	0.00121	0.00129	CcSEcCtD
Gonadorelin—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.00121	0.00129	CcSEcCtD
Gonadorelin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.00121	0.00129	CcSEcCtD
Gonadorelin—GNRHR—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.0012	0.0338	CbGpPWpGaD
Gonadorelin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.00116	0.00123	CcSEcCtD
Gonadorelin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00113	0.0012	CcSEcCtD
Gonadorelin—GNRHR—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.00112	0.0314	CbGpPWpGaD
Gonadorelin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.00112	0.00119	CcSEcCtD
Gonadorelin—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.0011	0.00117	CcSEcCtD
Gonadorelin—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.00108	0.00115	CcSEcCtD
Gonadorelin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.00105	0.00112	CcSEcCtD
Gonadorelin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.00111	CcSEcCtD
Gonadorelin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.00101	0.00108	CcSEcCtD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.001	0.0281	CbGpPWpGaD
Gonadorelin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.001	0.00107	CcSEcCtD
Gonadorelin—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000972	0.00104	CcSEcCtD
Gonadorelin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000967	0.00103	CcSEcCtD
Gonadorelin—Headache—Epirubicin—peripheral nervous system neoplasm	0.000957	0.00102	CcSEcCtD
Gonadorelin—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000908	0.000969	CcSEcCtD
Gonadorelin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000899	0.000959	CcSEcCtD
Gonadorelin—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000886	0.000945	CcSEcCtD
Gonadorelin—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00084	0.000896	CcSEcCtD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000741	0.0208	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00071	0.0199	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000644	0.0181	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000618	0.0173	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	0.000608	0.0171	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000564	0.0158	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000538	0.0151	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000493	0.0138	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000488	0.0137	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000451	0.0126	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000381	0.0107	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	0.000366	0.0103	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000365	0.0102	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000319	0.00894	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.00029	0.00812	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000289	0.00809	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000279	0.00782	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	0.000267	0.0075	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000266	0.00747	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000253	0.0071	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.0002	0.00561	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000176	0.00494	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000171	0.0048	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000163	0.00457	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.00015	0.0042	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000106	0.00297	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000104	0.00292	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.22e-05	0.0023	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.74e-05	0.00217	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.53e-05	0.00211	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.46e-05	0.00209	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.83e-05	0.00192	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.25e-05	0.00175	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.82e-05	0.00163	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.78e-05	0.00134	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.57e-05	0.00128	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.04e-05	0.00113	CbGpPWpGaD
